Trials / Recruiting
RecruitingNCT05706896
Atrophic Age-related Macular Degeneration Treated With Intravitreal Injections of Umbilical Cord Blood Platelet-rich Plasma
Atrophic Age-related Macular Degeneration (AMD) Treated With Intravitreal Injections of Umbilical Cord Blood Platelet-rich Plasma (CB-PRP): a Pilot Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study will be to evaluate the efficacy of intravitreal injections of Umbilical Cord Blood Platelet-rich Plasma (CB-PRP) in order to reduce or stabilize the atrophic progression in dry Age-related Macular Degeneration (AMD)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Intravitreal injection of CB-PRP | The procedure consists in a trans-scleral puncture to access the vitreous cavity, with subsequent injection of CB-PRP |
Timeline
- Start date
- 2022-12-14
- Primary completion
- 2023-06-09
- Completion
- 2026-02-10
- First posted
- 2023-01-31
- Last updated
- 2025-09-23
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05706896. Inclusion in this directory is not an endorsement.